Axogen (AXGN) Operating Income Growth (1y) (2011 - 2026)
Axogen (AXGN) Operating Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 16.18% |
| 10 | Axogen | 2.44 Bn | 2.33 Bn | 50.67 Mn | -228.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -228.95% |
| Mar 31, 2026 | -70.50% |
| Dec 31, 2025 | -584.48% |
| Sep 30, 2025 | 705.06% |
| Jun 30, 2025 | 490.65% |
| Mar 31, 2025 | 63.57% |
| Dec 31, 2024 | 163.15% |
| Sep 30, 2024 | 92.15% |
| Jun 30, 2024 | 93.80% |
| Mar 31, 2024 | 37.88% |
| Dec 31, 2023 | 43.05% |
| Sep 30, 2023 | 17.10% |
| Jun 30, 2023 | 12.90% |
| Mar 31, 2023 | 35.15% |
| Dec 31, 2022 | -4.76% |
| Sep 30, 2022 | 27.42% |
| Jun 30, 2022 | -10.76% |
| Mar 31, 2022 | -81.99% |
| Dec 31, 2021 | 0.39% |
| Sep 30, 2021 | -540.10% |